Emflaza Tablet
Product Images NDC 52856-502

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Emflaza (NDC 52856-502). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ptc Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula For Emflaza Is Deflazacort (a Corticosteroid).  corticosteroids Are Adrenocortical Steroids, Both Naturally Occurring And Synthetic.  the Molecular Formula For Deflazacort Is C25h31no6.  the Chemical Name For Deflazacort Is (11β,16β)-21-(acetyloxy)-11-hydroxy-2'-methyl-5'h-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione. (Emflaza 01)

Chemical structure of deflazacort, the active ingredient in EMFLAZA tablets. The diagram depicts molecular bonds and atom placements typical of the corticosteroid compound.*

FDA Label Image

Figure A (Emflaza 02)

An illustration showing components of EMFLAZA oral suspension packaging, including the oral suspension bottle, carton, household cup, and oral dispenser syringe, used for measuring and administering doses.*

FDA Label Image

Figure B (Emflaza 03)

An instructional illustration depicting a hand holding a bottle and shaking it vigorously, accompanied by the text "Shake Well." The image emphasizes the proper preparation step of shaking the liquid medication before use.*

FDA Label Image

Figure C (Emflaza 04)

An instructional black and white illustration showing a hand holding the neck of a bottle with arrows indicating where to apply pressure or twist, likely demonstrating how to open the bottle.*

FDA Label Image

Figure D (Emflaza 05)

An instructional illustration showing hands pressing down on the ribbed end of a bottle adapter using both thumbs, demonstrating how to open or activate the bottle cap.*

FDA Label Image

Figure E (Emflaza 06)

An illustration of a syringe labeled with parts including the plunger and barrel. The barrel is marked with measurement gradations for dosing.*

FDA Label Image

Figure F (Emflaza 07)

An instructional diagram showing a hand holding a syringe-like device labeled with a plunger, positioned above a bottle with an arrow indicating downward insertion. This suggests a step in the medication administration or preparation process.*

FDA Label Image

Figure G (Emflaza 08)

An instructional illustration showing how to measure a dose using an oral syringe, highlighting that the dose should be measured from the widest part of the plunger. The image depicts a hand holding the syringe and the liquid medication bottle attached at the top.*

FDA Label Image

Figure H (Emflaza 09)

An instructional diagram showing a hand holding a dosing syringe inserted into a bottle, demonstrating how to draw liquid medication by pulling the syringe plunger upward. An arrow indicates the direction to pull for filling the syringe from the bottle.*

FDA Label Image

Figure I (Emflaza 10)

An instructional illustration showing a hand holding a medication tablet above a glass of water with an arrow indicating the tablet is being dropped into the water, alongside a spoon resting next to the glass. This image likely demonstrates how to dissolve or prepare the medication for oral administration.*

FDA Label Image

Figure J (Emflaza 11)

An instructional illustration showing a hand holding a tablet and placing it into a cup of water. The image likely demonstrates medication administration by dissolution or mixing in water before oral intake.*

FDA Label Image

Figure K (Emflaza 12)

An instructional illustration depicting a hand lifting the flip-top cap of a bottle or container, showing the direction to open the cap by pulling upwards and away from the container neck.*

FDA Label Image

Figure L (Emflaza 13)

An instructional illustration showing a hand holding a syringe-like device labeled with 'Plunger' at the top and 'Barrel' at the middle. The plunger is being pulled upward with an arrow indicating the direction of movement.*

FDA Label Image

6 mg Tablet 100-count Bottle Label (Emflaza 14)

Label for Emflaza (deflazacort) tablets, 6 mg strength, oral use. The label shows 100 tablets and includes the NDC number 52856-501-01. It also lists storage instructions at 20°C to 25°C and states the product is manufactured by PTC Therapeutics, Inc. The design features a blue panel with dosage information and a barcode on the right.*

FDA Label Image

6 mg Tablet 100-count Carton Label (Emflaza 15)

Packaging label for Emflaza (deflazacort) 6 mg tablets for oral use. The label indicates a carton containing 100 tablets with the NDC 52856-501-01. Manufactured by PTC Therapeutics, Inc., the label includes dosage information stating each tablet contains 6 mg of deflazacort and storage instructions to keep at 20°C to 25°C (68°F to 77°F). The design features blue panels with white text and the PTC Therapeutics logo.*

FDA Label Image

18 mg Tablet 30-count Bottle Label (Emflaza 16)

Emflaza 18 mg tablets packaging label for oral use, containing 30 tablets. The label shows the active ingredient deflazacort at an 18 mg strength. It includes storage instructions to keep at 20°C to 25°C (68°F to 77°F) and notes to see the package insert for dosage and administration. The label is produced by PTC Therapeutics, Inc. and features the NDC code 52856-502-03.*

FDA Label Image

18 mg Tablet 30-count Carton Label (Emflaza 17)

Packaging label for Emflaza 18 mg tablets containing deflazacort. The label indicates oral use with a package count of 30 tablets. Manufactured by PTC Therapeutics, Inc., it includes storage instructions and dosage information, with the National Drug Code (NDC) 52856-502-03 displayed. The label background is primarily white with orange panels highlighting the product name and strength.*

FDA Label Image

30 mg Tablet 30-count Bottle Label (Emflaza 18)

Emflaza (deflazacort) 30 mg tablets packaging label for oral use. The label states the product contains 30 tablets, each with 30 mg deflazacort. Includes storage instructions to keep at 20°C to 25°C (68°F to 77°F). Marked as prescription only (Rx). Labeler is PTC Therapeutics, Inc. The label also includes the NDC 52856-503-03 and a barcode with FPO text.*

FDA Label Image

30 mg Tablet 30-count Carton Label (Emflaza 19)

Packaging label for Emflaza (deflazacort) tablets, 30 mg strength, for oral use. The label indicates the product is prescription-only, contains 30 tablets per package, and is manufactured by PTC Therapeutics, Inc. The label displays the NDC number 52856-503-03 and storage instructions between 20°C to 25°C (68°F to 77°F).*

FDA Label Image

36 mg Tablet 30-count Bottle Label (Emflaza 20)

Emflaza (deflazacort) 36 mg tablets for oral use, labeled as prescription only, with 30 tablets per container. The label includes storage instructions, dosage strength, and the labeler PTC Therapeutics, Inc. The packaging also shows the NDC 52856-504-03 and a barcode with an FPO watermark.*

FDA Label Image

36 mg Tablet 30-count Carton Label (Emflaza 21)

Packaging label for Emflaza (deflazacort) 36 mg tablets for oral use. The label shows a 30-tablet count with a brown and white color scheme. The product is manufactured by PTC Therapeutics, Inc. The label includes the NDC 52856-504-03 and storage instructions at 20°C to 25°C. The label features the PTC Therapeutics logo.*

FDA Label Image

22.75 mg/ml Oral Suspension 13 mL Bottle Label (Emflaza 22)

Label for Emflaza (deflazacort) Oral Suspension with a concentration of 22.75 mg/mL in a 13 mL bottle. The label includes dosage and storage instructions, manufacturer details (PTC Therapeutics, Inc.), and directions for oral administration only. It is marked Rx only.*

FDA Label Image

22.75 mg/ml Oral Suspension 13 mL Carton Label (Emflaza 23)

Packaging label for Emflaza (deflazacort) Oral Suspension 22.75 mg/mL in a 13 mL bottle by PTC Therapeutics, Inc. The label includes dosage form, strength, NDC 52856-505-22, storage instructions, and contents of the carton including two 1 mL oral dispensers and a press-in bottle adapter. The product is for oral administration only and is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.